Oral Session 2-7A PTCL/NK lymphoma: Clinicopathology

[OS2-7A-2] Evaluation of prognosis for early disease progression in peripheral T-cell lymphoma

Yasuhiro Suzuki^1,2, Takahiro Yano³, Youko Suehiro⁴, Hiromi Iwasaki⁵, Michihiro Hidaka⁶, Maki Otsuka⁷, Kazutaka Sunami⁸, Nobumasa Inoue⁹, Morio Sawamura¹⁰, Takuo Ito¹¹, Hiroatsu Iida¹, Hirokazu Nagai¹ (1.Hematol., NHO Nagoya Medical Center, Nagoya, Japan, 2.Hematol., Gifu Prefectural Tajimi Hospital, Tajimi, Japan, 3.Hematol., NHO Tokyo Medical Center, Tokyo, Japan, 4.Hematol., NHO Kyushu Cancer Center, Fukuoka, Japan, 5.Hematol., NHO Kyushu Medical Center, Fukuoka, Japan, 6.Hematol., NHO Kumamoto Medical Center, Kumamoto, Japan, 7.Hematol., NHO Kagoshima Medical Center, Kagoshima, Japan, 8.Hematol., NHO Okayama Medical Center, Okayama, Japan, 9.Hematol., NHO Osaka Medical Center, Osaka, Japan, 10.Hematol., NHO Shibukawa Medical Center, Shibukawa, Japan, 11.Hematol., NHO Kure Medical Center, Kure, Japan)